Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community (MOSAR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Information provided by:
Tel-Aviv Sourasky Medical Center Identifier:
First received: October 6, 2008
Last updated: October 15, 2008
Last verified: October 2008
Data on occurrence of antimicrobial resistant bacteria acquisition in rehabilitation centers will be collected. After removal of patient identifiers, information regarding the patients population will be entered into electronic sheet. The phase will last twelve months in each center.

ESBL Infection
Methicillin-Resistant Staphylococcus Aureus

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community

Resource links provided by NLM:

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Primary Outcome Measures:
  • A rehabilitation center's department in which the hospitalized patients are older then 18 years old. [ Time Frame: 1 YEAR ] [ Designated as safety issue: No ]

Estimated Enrollment: 1200
Study Start Date: October 2008
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
rehabilitation center's hospitalized patients

Detailed Description:

All patients admitted to the department will be examined on admission, two weeks latter and monthly by obtaining nares and perirectal cultures. These cultures will be processed for detection the target organisms. This activity is part of the good medical practice and is performed on routine basis in various hospital units

Epidemiological data will be collected from patient records. This data will be stored after removal of all patients' identifiers. These data will be transferred for analysis to Tel Aviv Medical Center


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A rehabilitation center's department in which the hospitalized patients are older then 18 years old.

Inclusion Criteria:

  • Hospitalized patients are older then 18 years old

Exclusion Criteria:

  • Age 18 years or less
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00773799

Contact: yaffa lerman, MD 97252-4266910

Tasmc Not yet recruiting
Tel-aviv, Israel, 64239
Contact: Yaffa lerman, md    97252-4266910   
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Principal Investigator: Yehuda carmeli, MD MPH TASMC
  More Information


Responsible Party: yehuda carmeli, TASMC Identifier: NCT00773799     History of Changes
Other Study ID Numbers: TASMC-08-YC-239-CTIL
Study First Received: October 6, 2008
Last Updated: October 15, 2008
Health Authority: Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:
To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.
ESBL producers

Additional relevant MeSH terms:
Staphylococcal Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses processed this record on November 27, 2015